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Abstract
Background: The aim of this review is to systematically investigate the effect of a susceptible genotype to peri-
odontitis with the clinical outcomes of periodontal regeneration.
Material and Methods: Based on a focused question, an electronic search identified 155 unique citations. Three 
journals (Journal of Periodontology, Journal of Clinical Periodontology and Journal of Periodontal Research), 
references of relevant studies and review articles were hand-searched. Two independent reviewers implementing 
eligibility inclusion criteria selected the studies. 
Results: Of the 155, four studies fulfilled the inclusion criteria. All studies were published between 2000 and 2004 
and the samples’ size was 40 to 86 patients. Polymorphisms of Interleukin-1 (IL-1) gene were included in all. 
Three out of four studies failed to identify an association between susceptible genotypes to periodontitis and clini-
cal outcomes of periodontal regeneration, while one found an association. The heterogeneity and small number of 
studies included prevented the conduct of a meta-analysis. No studies were identified evaluating the effect of other 
genotypes and as a result only IL-1 genotype studies were included. 
Conclusions: Within the limits of the present review, no direct conclusion for the effect of a susceptible IL-1 geno-
type status to the clinical outcome after periodontal regeneration could be drawn. The need of more qualitative 
studies to explore a possible association emerges.
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Introduction
Periodontal therapy aims in reducing the tissue inflam-
mation caused by bacterial plaque, preventing further 
loss of attachment while aiming as well in regenerat-
ing the anatomical bone structures around teeth (1,2). 
Non-surgical as well as surgical periodontal treatment 
results in a reduction of periodontal probing depth thus 
facilitating patient’s oral hygiene (2). However peri-
odontal treatment does not provide or provides minimal 
regeneration of the compromised tissues. Consequently, 
other surgical procedures, such as osseous grafting and 
guided tissue regeneration, emerged as means of pro-
viding a more predictable and long term stable result in 
regeneration of the periodontal tissues (1).
Bone replacement graft, is one of the most commonly 
encountered therapeutic approaches when dealing with 
osseous defects (3). Autogenous bone grafts, from ex-
tra-oral or intra-oral donor sites, allogenic bone grafts, 
alloplasts and xenografts are all used in periodontal os-
seous defects (1). Bone grafting is considered a better 
therapeutic technique for intrabony defects than open 
flap debridement, while when combined with the use 
of membranes even better clinical outcomes have been 
reported (3). The clinical outcome of bone replacement 
graft may vary. The type of graft biomaterials and the 
techniques used, such as the flap design, suturing tech-
nique and the anatomy of the defect, affect the outcome 
(4).
Guided tissue regeneration (GTR) is a periodontal 
surgical procedure introduced in the early 80s aim-
ing in the regeneration of all the anatomical structures 
around the teeth, including the cementum, periodontal 
ligament and alveolar bone (1,5). In GTR, the use of a 
biocompatible barrier membrane (resorbable or nonre-
sorbable) assures the maintenance of an adequate space 
for bone and other attachment tissues to cover the os-
seous defect and prevent the migration of the epithelial 
and gingival connective tissue (2). GTR is reported to 
result in a greater gain of clinical attachment, probing 
depth reduction and filling of deep intrabony defects 
when compared to open flap debridement as presented 
in two systematic reviews (6,7). The clinical outcome of 
periodontal regeneration with GTR may be affected by 
smoking, high plaque scores, bleeding on probing, deep 
periodontal pocket depth and the anatomical character-
istics of the defect (2).
Enamel Matrix proteins were also found to regenerate 
the periodontal tissues since amelogenins were found to 
mimic the events during the development of the perio-
dontal tissues (8,9). The cells of the Hertwig’s epithelial 
root sheath were found to produce enamel matrix pro-
teins on the root surface before the cementum forma-
tion (9). Enamel matrix derivative (EMD) was found to 
provide an additional gain of clinical attachment levels 
of 1.3mm as well as provide greater reduction of prob-
ing depth that ranged from 1.0 mm to 1.6 mm (4). The 
use of EMD is presented as equally effective as guided 
tissue regeneration (4). 
Back in 1966 a study counting over 1800 individuals, 
identified the presence of a subgroup of patients who 
possessed a greater risk of developing periodontitis (10). 
Later, Michalowicz et al. (11) found that a variance of 
periodontal status could be attributed to genetic factors 
in 38% to 82% of the population. An increasing number 
of studies strongly associate some host genetic factors 
with the onset of periodontal disease (12). Interleukin-1 
(IL-1) is one of the most studied polymorphism of the 
human genome that influences periodontal disease. The 
influence of susceptible genotypes of IL-1 in periodon-
tal therapy outcome and progression has recently drawn 
attention (13,14). 
Similarly, a susceptible genotype to periodontal disease 
may influence the outcome of the periodontal regenera-
tion as well. Hence, the purpose of this study was to as-
sess systematically the association between susceptible 
genotypes to periodontitis and the clinical outcomes of 
periodontal regeneration therapy.
Material and Methods
- Review question
What is the effect of a susceptible genotype to peri-
odontitis following periodontal regeneration therapy 
on the clinical parameters of periodontal disease, such 
as probing depth (PD), clinical attachment level (CAL), 
gingival recession (REC), bleeding on probing (BOP) 
and plaque index (PI), when compared to non-suscep-
tible genotypes?
- Literature review
A search was undertaken to identify all clinical studies 
that investigated the association between the suscepti-
bility to periodontitis genotypes and the clinical out-
comes of periodontal regeneration treatment. 
Longitudinal clinical studies that were published up 
to May 2014 (week 4) were identified electronically 
(MEDLINE, SCOPUS Elsevier and Cochrane Library). 
The search was conducted in May (week 4) using ten 
(10) keywords and included papers published up until 
that time point. The terms “Periodontal regeneration”, 
“Regenerative periodontal therapy”, “Guided tissue re-
generation”, “Guided bone regeneration”, “Periodontal 
therapy”, each joined by the connector OR were linked 
by the Boolean connector AND to the terms “polymor-
phism, genetic”, “polymorphism”, “genotype”, “haplo-
type”. In three journals (3) (Journal of Periodontology, 
Journal of Clinical Periodontology and Journal of Peri-
odontal Research), references of all relevant studies and 
review articles were hand-searched. No specific lan-
guage restriction was applied to any of the searches.
- Study selection
Two investigators (G.C,V.K) screened independently 
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the titles and abstracts of all the articles identified in 
the electronic and manual search. Articles which met 
the following inclusion criteria were included in the re-
view:
● Prospective and retrospective cohort studies; 
Including systemically healthy patients, aged >18 years 
and with at least one infrabony defect.
● Studies relating the influence of susceptible geno-
types to periodontitis on the clinical outcome of peri-
odontal regenerative therapy.
● An observation time period of at least 6 months after 
therapy was mandatory.
● Evaluation of the clinical outcome with the use of 
one or more of the clinical parameters: probing pocket 
depth (PPD), clinical attachment level (CAL), bleeding 
on probing scores (BOP), plaque index (PI), gingival re-
cession (REC) before and after therapeutic procedure;
No language restriction was applied. However, elec-
tronic search included at least a title in English. None of 
the articles which met the inclusion criteria was written 
in a language other than English. In case of disagree-
ment between the reviewers, discussion was utilised for 
resolution.
- Data extraction
The data was extracted independently by the two re-
viewers (G.C and V.K) and was presented into two tables 
consisting of general information for the studies (author, 
year of publication, journal), source of the sample, loca-
tion of the polymorphism, studies’ protocols, clinical 
parameters that were used to evaluate the periodontal 
regeneration therapy outcomes and the studies’ conclu-
sions. A second table was used to extract data related to 
the sample’s characteristics depending on the genotype 
profile (positive or negative), such as age, distribution of 
the sample with respect to gender, systemic condition, 
administration of antibiotics, smoking habits, regenera-
tion site, defect morphology and ethnicity. In the same 
table the duration of the follow-up was recorded.
The quality assessment of the included case control 
studies was assessed with the use of the Newcastle-
Ottawa Scale (NOS) (15). The modified NOS was used 
as described by Chambrone et al. (16) and assessment 
of selection, comparability, exposure and statistical bias 
were performed.
Results
Initial electronic searches identified 155 publications. 
After screening of the titles and abstracts independent-
ly, 12 (14,17-27) studies were selected for full-text re-
view (Fig. 1). The other 143 publications were excluded 
due to the irrelevant topic. All identified papers in first 
selection included at least a title in English. None of the 
included papers were in a language other than English 
and thus translation of the abstract or/and the main text 
was not required for any paper. Inter reviewer agree-
ment at the first phase of selection was very high (k = 
0.92). After full-text and citation mining, four articles 
were identified as determined by the inclusion and ex-
clusion criteria (k=0.98). Of the four articles, three (25-
27) were initially identified by electronic search, while 
the other one (28) by citation mining. 
The review of the 12 full text studies resulted in the 
exclusion of nine articles (14,17-24) due to lack of peri-
odontal regeneration intervention included in the study 
protocol. All of those studies employed open flap deb-
ridement without periodontal regeneration. At the same 
time, only studies evaluated the influence of the pres-
ence of IL-1 positive genotype on the clinical outcome 
of periodontal regenerative therapy were identified in 
the literature.
- Study characteristics are presented in tables 1,2. 
The studies were published between 2000 and 2003 and 
the included sample was patients from dental schools. 
The effect of IL-1 genotype status on the clinical out-
come of the guided tissue regeneration (25,26,28) and 
the bone replacement grafts (27) was investigated in the 
studies. One study was prospective cohort (25), while 
the other three were retrospective cohort studies. 
The first study was published by DeSanctis and Zucchel-
li in 2000 (25), and included 14 patients with positive 
genotype to periodontitis and a mean age of 45 years. 
All of them were systematically healthy and three were 
smokers. The minimum follow-up was 12 months and 
ranged between 12 and 48 months. The investigators 
used non-absorbable ePTFE membranes and concluded 
that the genotype did not affect the treatment outcome 
in the first year of follow up (p>0.05). However, in the 
fourth year patients susceptible to periodontitis exhib-
ited significant CAL loss (p<0.002), significant PPD in-
crease (p<0.001) and more unstable regenerated attach-
ment compared to negative genotype patients.
The patients of Christgau et al. (26) and Cortellini and 
Tonetti (28) were controlled for the same IL-1 genetic 
polymorphism. Both studies used the same therapeutic 
intervention of guided tissue regeneration. Non-resorb-
able or absorbable membranes were used for the intrab-
ony defects’ treatment, while Cortellini and Tonetti (28) 
combined the absorbable membranes with alloplastic 
biomaterials. The study of Christgau et al. (26) included 
18 non-smokers, Caucasians with positive genotype pa-
tients. They found no significant association between 
the genotype and the clinical and radiographic outcome 
after GTR treatment. In addition, no significant influ-
ence of the IL-1 genotype was recorded on the clini-
cal outcome of periodontal regenerative therapy of 86 
patients in another study (28). In the particular study 32 
(37.2%) of the individuals included were genotype posi-
tive and the mean follow up period was 7.5 years for the 
IL-1 positive subjects and 8.7 for the IL-1 negative. 
Allografts, xenografts or alloplasts bone grafts were 
employed in the treatment of inter-proximal periodon-
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Fig. 1. Search and selection results.
tal defects of Caucasians and Hispanics in a study pub-
lished by Weiss et al. (27). 13 of the 44 (29.5%) included 
individuals were found susceptible to periodontitis after 
genotyping. The genotype positive patients had a mean 
age of 47 years and four of them were smokers. This 
study showed that no association was found between 
the genotype status and the outcome of the bone graft-
ing. IL-1 positive patients exhibited less PPD reduction 
and more clinical attachment gain than the IL-1 nega-
tive patients, but the difference was not found statistical 
significant (p>0.05).
Bias assessment were assessed by the use of the modi-
fied NOS-Scale regarding the study design (selection, 
comparability, outcome and statistics). Bias assessment 
revealed that the quality of the included studies ranged 
and a significant heterogeneity of the quality according 
to the Newcastle-Ottawa Scale found. The scores of the 
included studies are presented in table 3. 
No meta-analysis of the data from the included studies 
was performed. Apart from the small number of includ-
ed studies and the reduced clinical significance of such 
an effort, several differences in the treatment protocols 
and the quality assessment were identified between the 
studies.
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 Also presented in table 1 the characteristics of the study 
design for each of the included studies. In one study 
(27), regenerative procedure consisted of bone replace-
ment grafts, while in the other three included studies 
guided tissue regeneration with different types of mem-
branes was employed.
Discussion
- Summary of evidence
No definitive conclusion, based on combination of the 
of the included studies’ data, can be provided. However, 
most of the included studies conclude that the clinical 
outcome of the periodontal regenerative procedures is 
Publication Source of the sample 
Polymorphis
m location 
Regeneration 
procedure 
Therapeutic 
procedure 
Clinical and 
radiographic 
measurements 
Authors’ Conclusion 
DeSanctis and 
Zucchelli (25) 
Patients 
from dental 
school 
IL-1A 
(+4845),  
IL-1B (+3953) 
GTR Non-absorbable 
ePTFE 
membranes 
Plaque scores, BOP, 
CAL, PD, REC,  
Genotype expression 
did not effect GTR 
treatment response at 
1 year. Greater impact 
on long-term stability 
(year 4). 
Christgau et al. 
(26) 
Patients 
from dental 
school 
IL-1A (-889),  
IL-1B (+3953) 
GTR Non-resorbable 
membranes e-
PTFE, 
resorbable 
membranes 
(Polyglactin-
910, Polylactic 
acid, 
Polydioxanon) 
PBI, REC, PD, CAL, 
vertical 
relative attachment 
gain, depth of 
the osseous defect, 
bone 
changes (density, 
area) in the defect 
area 
IL-1 gene 
polymorphism has no 
influence on the 
clinical and 
radiographic 
regeneration results 
Cortellini and 
Tonetti (28) 
Patients 
from dental 
school, 
referrals 
IL-1A (-889),  
IL-1B (+3953) 
GTR Non-resorbable 
or absorbable 
barrier 
membranes or a 
combination: 
absorbable 
membranes and 
alloplastic 
biomaterials 
Plaque scores, 
bleeding scores, 
CAL, PD, REC, 
width of the 
radiographic angle of 
the defect. 
No significant effect 
of IL-1 genotype 
status was observed 
Weiss et al. (27) Patients 
from dental 
school 
IL-
1A(+4845),  
IL-1B (+3954) 
Bone 
replacement 
grafts 
Allografts, 
xenografts or 
alloplasts bone 
graft 
PD, CAL, BOP, 
plaque index 
No evidence that the 
IL-1 genotype 
influenced the 
outcome of 
regenerative 
periodontal therapy 
with bone replacement 
graft 
 
Table 1. Characteristics of the publications.
PBI: Papillary bleeding index
PD: Probing depth
CAL: Clinical attachment loss
BOP: Bleeding on probing
REC: Recession
e-PTFE: Expanded polytetrafluoroethylene
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not influenced by the presence of a susceptible geno-
type to periodontal disease such as IL-1. On the other 
hand, one study (25) reported a greater impact of the 
IL-1 genotype in the long-term stability of the clinical 
outcome in terms of sustained attachment levels. From 
those results it can be concluded that it seems that no 
additional negative effect of IL-1 genotype in regenera-
tive periodontal treatment exists although better con-
trolled studies should be employed. The lack of well 
controlled studies evaluating the relationship between 
IL-1, or even other genotypes less popular today, may 
shed some light in the individuals’ healing variations 
often observed after regenerating procedures. Although 
we may stand at an early time point, and this can be 
reflected in the small number of studies included in the 
present review, however there is increasing interest for 
patients exhibiting susceptible genotypes as the regen-
erative procedures are now employed in the everyday 
periodontal practice.
Christgau et al. (26), Cortellini and Tonetti (28) and 
Weiss et al. (27) concluded that there is no influence of 
the IL-1 genotype on the clinical outcomes. De Sanctis 
and Zucchelli (25) recorded an association of the gen-
otype with the clinical result after regenerative treat-
ment. In this study, an influence of the genotype on the 
stability of the gained attachment level after the regen-
erative procedure was reported. IL-1 positive patients 
were more prone in loss of CAL in the regenerated de-
fect between the first and the fourth year of the follow-
up period. The PPD increase and the CAL loss in the 
intrabony defects that were treated with GTR exhibited 
to be statistical significant (p=0.0001) in IL-1 genotype 
positive patients compared with IL-1 genotype negative 
subjects. Weiss et al. (27) wanted to evaluate the sta-
Publication Genotype Sample Age range Mean age Males Females Antibiotics Smoking Ethnicity 
Follow-up 
(min) 
Follow-up 
(mean) 
De Sanctis and 
Zucchelli 
(25) 
Positives 14 37-53 45 9 5 YES 3 NR 12 12-48 
Negatives 26 36-56 46 10 16 YES 5 NR 12 12-48 
Christgau et al. 
(26) 
Positives 19 NR 47 10 9 YES NO Caucasians 12 NR 
Negatives 28 NR 49.5 8 20 YES NO Caucasians 12 NR 
Cortellini and 
Tonetti 
(28) 
Positives 32 NR NR NR NR YES NR NR 64,8 90 
Negatives 54 NR NR NR NR YES NR NR 104,4 8,7 
Weiss et al. 
(27) 
Positives 13 28-74 47 10 3 NR 4 Caucasians, 
Hispanics 
NR 37.38 
Negatives 31 37-78 56.2 13 18 NR 11 Caucasians, 
Hispanics 
10 44.65 
 
 
Table 2. Characteristics of the sample population.
 SELECTION COMPARABILITY OUTCOME STATISTICS 
Publication Q1 Q2 Q3 Q4 Q5 Q6 Q1 Q2 Q1 Q2 Q1 Q2 
DeSanctis and Zucchelli 
(25) 
* * * *  * * * * * * * 
Christgau et al. 
(26) 
* * * * *   * * * * * 
Cortellini and Tonetti 
(28) 
* * *     * *  *  
Weiss et al. 
(27) 
* * * *   * * * * *  
 
Table 3. Quality assessment of the included studies.
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bility of the clinical outcome after four years of follow 
up just as De Sanctis and Zucchelli (25) did. They con-
ducted an analysis in a subgroup of patients that were 
re-examined four years after treatment. No significant 
differences were found as far as the stability was con-
cerned between the IL-1 positive and IL-1 negative sub-
jects. 
All four studies reported on systemically healthy pa-
tients thus excluding systemic conditions as confound-
ers in the treatment outcome. Many epidemiological 
studies have correlated periodontal disease with sys-
temic conditions, especially diabetes (29). Diabetes 
mellitus and periodontitis are interrelated and each one 
of them affect the clinical outcome of the other (30). 
Moreover, periodontal disease onset and progression 
might be influenced by other systemic diseases such 
as obesity, metabolic syndrome and osteoporosis (31). 
A potential effect of the aforementioned factors on the 
clinical outcome of regenerative periodontal therapy, 
led to the necessity of including only systematically 
healthy individuals (31).
In the included studies the investigators preceded non-
surgical periodontal therapy (scaling and root planing) 
including oral hygiene instructions before the surgi-
cal intervention for ensuring elimination of etiological 
factors and control of the inflammation. Kaldahl et al. 
(32), showed that scaling and root planing was similarly 
effective in pocket depth reduction, attachment level 
change and diminishment of inflammation as surgical 
treatment in long term follow up (32). Lindhe and Ny-
man (33) have shown in a longitudinal study that peri-
odontitis can effectively been treated with scaling and 
root planing and surgical intervention followed by good 
oral hygiene control in a five-year period (33). 
In another study, oral hygiene was found to be a deter-
minant of gingival health maintenance as shown in the 
study of Cortellini and Tonetti (28) where a 3-month 
recall program was shown to be effective in maintain-
ing low plaque scores, reduced bleeding in probing, P. 
gingivalis and P. intermedia and stable attachment lev-
els four years after guided tissue regeneration in deep 
infra bony defects. In addition, less stringent supportive 
periodontal treatment was found to consist a 50 fold up 
increased risk for attachment level loss (34). The impor-
tance of plaque control was also supported by Hellstrom 
who reported that a stringent oral hygiene regimen with 
often professional supervision improved the clinical in-
dexes and reduced the subgingival microbiota at infra 
bony, supra bony defects and furcation sites (35).
Smoking is considered a well evidenced risk factor for 
periodontal disease, while smoking habits were found 
to influence the periodontal regenerative therapy as well 
(36,37). The clinical outcome of GTR and bone replace-
ment grafts was found to be compromised in smokers 
when compared to non smokers. Based in a subgroup 
of three studies, a meta-analysis showed statistically 
significant reduced bone gain (p = 0.03) after GTR of 
intrabony defects in smokers (38). In only one study of 
the current review (26) the sample consisted of non-
smokers, whereas the other three studies (25,27,28) 
included both smokers and non-smokers. Weiss et al. 
(27) found a non-statistically significant association of 
smoking and clinical outcome despite the fact that the 
IL-1 positive patients exhibited less reduction of PPD 
than IL-1 negatives. De Sanctis and Zucchelli (25) did 
not perform separate analysis for a possible confound-
ing of smoking habits to the periodontal regenerative re-
sult. However the smoker individuals included counted 
for only eight individuals. It is worth noting that in the 
study of Cortellini and Tonetti (28) all of the teeth lost in 
follow up (6) belonged in smokers. Consequently, smok-
ers were found to possess a greater tendency to lose the 
initial gain when compared to non-smokers. None of the 
studies however investigated the role of smoking habits 
for the IL-1 positive and IL-1 negative genotype patients 
and the clinical outcome of the regenerative therapy. 
Other factors that influenced the clinical outcome of re-
generative periodontal therapy were reported as well. 
The baseline PPD of the intrabony defects was found 
to affect the PPD and CAL after therapy (25), while the 
full-mouth plaque score was found to influence the gain 
of attachment levels (25,27). Cortellini and Tonetti (28) 
concluded apart for smoking, the absence of compliance 
in periodontal maintenance affects negatively the treat-
ment outcome. Accordingly in particular study (28), 
five out of the six teeth lost in follow up were attributed 
patients presenting poor compliance. 
As far as the defect morphology is concerned evidence 
shows that the wall distribution as described by Prichard 
(39) plays a critical role in the regenerative result. None 
of the included studies however provided evidence for 
the characteristics of the infra bony defects either in 
terms of wall composition or in terms of depth and an-
gle with the neighbouring tooth (40).
Finally, the location of the regenerative site is considered 
to play a crucial role in the regenerative potential. In the 
included studies of the current review no information is 
provided by the authors concerning the location of the 
sites in the anterior or posterior zone. Only De Sanctis 
and Zucchelli  (25) report on the location of the regen-
erative site, including 11 incisors 8 cuspids, 6 premolars 
and 6 molars. In addition, Cortellini and Tonetti (28) 
report only on the site of the lost teeth, where six out of 
six teeth lost during follow up were anterior teeth. 
- Limitations-Future studies
One of the main limitations of the included studies was 
reporting on a limited number of patients. The study 
populations were characterised as small and asymmet-
ric between the IL-1 genotype positive and IL-1 geno-
type negative patients. In one study (27) only 13 patients 
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with positive genotype were included and the researchers 
concluded that there was no influence between clinical 
outcome and the genotype. Consequently, the sample of 
the studies may require caution in the interpretation of 
the results.  
In the current systematic review, the included cohort 
studies did not include sufficient number of smokers that 
could lead to a safe conclusion. The small number of 
smokers as well as the heterogeneity between smokers 
as reported by the authors prevented the conclusion on 
the correlation of genotype and smoking with the clinical 
outcome of regenerative therapy of periodontal disease.
Furthermore, despite the rapid development of genet-
ics and the discovery of new genes that may be associ-
ated with periodontal disease, research evaluating the 
impact of the genetic factor in periodontal regenerative 
therapy outcome is lacking. The research in that field is 
limited to IL-1, while the research around the impact of 
the polymorphisms in non-surgical periodontal therapy 
nowadays includes various genes, such as IL-4, IL-6, 
IL-8, MMP-1, MMP-13 and MBL (41).
Ten years have passed since the last publication that ex-
amined the influence of genetic factors on the clinical 
outcome of periodontal regenerative therapy. In the fu-
ture, prospective cohort studies with larger sample size 
should be conducted in order to examine the effects of 
single nucleotide polymorphisms of various genes on 
the clinical outcome of regenerative periodontal therapy 
that is evolving to become an everyday practice of peri-
odontology.
Conclusions
Within the limits of the present review, no direct con-
clusion for the effect of a susceptible genotype status 
(for IL-1) in the clinical outcome after periodontal re-
generation could be drawn. However the studies afore-
mentioned provide some evidence that a susceptible 
IL-1 genotype may not negatively affect the clinical pa-
rameters evaluated for a minimum of 6 months follow-
ing regenerative surgery. The need of more qualitative 
studies to explore a possible association emerges.
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